US Digestive Health Executive and Leadership Team

Scott Bennett, the Chief Executive Officer at US Digestive Health, directs the overarching strategy and operational framework for the organization. Bennett oversees the integration of advanced technologies, including AI-enabled screening, to enhance early detection and prevention of colorectal cancer. This leadership role involves guiding the expansion of services across Southeastern, Central, and Southwestern Pennsylvania and Delaware, ensuring a patient-centered approach is maintained. Bennett drives the company's mission to redefine digestive care excellence by fostering innovation and optimizing patient outcomes. The Chief Executive Officer ensures alignment with market demands and the strategic growth objectives of the practice. Scott Bennett's focus remains on elevating the standard of care through efficient operations and a commitment to patient health.

Bruce Gonyea, the Chief Executive Officer & Co-Founder at US Digestive Health, spearheads the strategic vision and foundational principles of the practice. Gonyea guides the expansion and operational scaling across numerous locations in the Northeast region, ensuring the delivery of cutting-edge gastroenterology care. This leadership position involves championing the company's dedication to personalized treatment plans and early detection of digestive diseases. Bruce Gonyea oversees the integration of state-of-the-art technology and telehealth options to enhance patient access and convenience. The Chief Executive Officer & Co-Founder is pivotal in maintaining the company's patient-centered approach and commitment to improving health outcomes. Gonyea's strategic direction ensures US Digestive Health remains at the forefront of digestive care innovation. Bruce Gonyea's influence shapes the practice's growth and its reputation for excellence.

Yamaira Alicea, the Chief Financial Officer at US Digestive Health, manages the financial health and strategic fiscal planning for the organization. Alicea oversees all financial operations, including budgeting, forecasting, and resource allocation across the company's numerous locations. This role is critical in supporting the delivery of advanced gastroenterology services and the implementation of cutting-edge technologies. The Chief Financial Officer ensures financial stability and drives initiatives that enhance operational efficiency and patient access to care, including telehealth options. Yamaira Alicea's expertise supports the company's mission to redefine digestive care excellence and expand its reach throughout Pennsylvania and Delaware. Alicea's financial acumen underpins the sustainable growth and strategic development of US Digestive Health. Yamaira Alicea's leadership ensures robust financial management supporting patient-centered care.

Dale Whitebloom, the Chief Medical Officer at US Digestive Health, directs the clinical strategy and ensures the highest standards of patient care across all practice locations. Whitebloom oversees the implementation of advanced procedures, such as colonoscopies, and the integration of AI-enabled screening technologies for early detection and prevention of colorectal cancer. This leadership position is vital in maintaining the company's patient-centered approach and commitment to personalized treatment plans. The Chief Medical Officer guides the clinical teams in delivering cutting-edge gastroenterology services, including fast-track colonoscopy and telehealth options. Dale Whitebloom's medical expertise ensures adherence to best practices and drives innovation in digestive health. Whitebloom's focus is on enhancing patient outcomes and redefining excellence in digestive care throughout Pennsylvania and Delaware. Dale Whitebloom's clinical leadership is central to the practice's mission.